SAS presents HSBC, Lilly, Philippines Bureau of Internal Revenue Enterprise Intelligence Awards

Companies honored for innovative deployment of software solution

SAS GLOBAL FORUM, SAN ANTONIO, TEXAS  (17 Mar. 2008)  –  SAS, the leader in business intelligence, annually recognizes customers that effectively use SAS^® technologies to empower decision makers to act with confidence to meet business goals. This year, SAS Enterprise Intelligence Awards are presented to HSBC, Eli Lilly and Company and the Bureau of Internal Revenue (BIR) of Republic of the Philippines at SAS Global Forum in San Antonio, Tex.

SAS honors HSBC as the development partner for SAS Fraud Management, a real-time card fraud detection system. Already implemented in the US and rolling out in the UK and Asia, the solution helps HSBC uncover fraudulent transactions quickly and with unprecedented accuracy.

In just three months, HSBC increased card transaction and customer information processing 87 percent while reducing mainframe processing overhead 12 percent, resulting in a 53 percent decrease in mainframe processing cost per data item. Overall, the computing resource cost of processing potentially fraudulent card transactions has come down 30 percent, with a 10 percent increase in efficiency by agents investigating potentially fraudulent cases.

“Our success with this partnership and with SAS Fraud Management shows that SAS understands and shares in HSBC’s long-term goals and can work with us to deliver improved solutions,” said Derek Wylde, Head of Group Fraud Risk at HSBC. “We both emerge as winners since SAS technology helps us in the fight against fraud.”

Lilly earns its EIA for employing SAS Drug Development to speed the delivery of excellent, marketable drugs from the laboratory to the patient. The solution, which provides a centralized, integrated system for managing, analyzing, reporting and reviewing clinical research information, helps Lilly accelerate the scientific clinical process, improve global collaboration and operational efficiencies, and facilitate regulatory compliance during drug development.

SAS Drug Development gives Lilly a common mechanism for organizing critical data, both for submitting new drugs and developing innovative products. With information easily shared or transferred globally, the comprehensive suite of tools complements Lilly’s proven talent for delivering fast, innovative results. Additionally, the common platform helps maintain consistency among teams with outsourcing partners, helping share work more easily and shift resources when needed. This flexibility helps Lilly maintain more predictable timelines while achieving operational efficiency, scientific consistency and product integrity. Lilly expects to save $11.3 million per year through increased productivity and efficiency by 2010, and an additional $2.7 million by retiring the legacy system SAS is replacing.

“SAS is at the heart of the vast majority of our clinical analyses, which are used by decision makers at many levels and at many steps along the way to determine whether to proceed with or abandon drugs in the pipeline,” says Todd Sanger, Ph.D., Lilly’s Director of Global Statistical Sciences.  “And regulatory agencies like the FDA can trust our data and our analyses because they use SAS, too. With the broad use of SAS across the pharmaceutical industry, one could consider SAS as the industry standard.”

BIR’s award comes from implementing SAS as their Enterprise Data Warehouse. The project was initially incepted for revenue generation through enhanced tax collection using analytics for intelligent matching for its “Reconciliation of Listings for Enforcement” (RELIEF). “For many years, some taxpayers would deliberately try to confuse us, and they were very determined not to provide us with required information,” explains BIR CIO and Deputy Commissioner Lilia C. Guillermo. “In fact, SAS’ analytic intelligence allows us to match all VAT tax declarations against tax importations from the customs database to generate discrepancy analysis reports. We exchange information with other government agencies where all of this data is stored in our SAS data warehouse. The taxpayers are now aware that we have accurate information about them.”

On the first run of SAS, the BIR has identified tax discrepancy ratio as high as 90 percent and have uncovered approximately 70 billion PhP (US$1.750B) in under declarations and around 7 billion PhP (US$175M) have been collected. “The return on investment on SAS software is huge,” agrees Guillermo. “All you have to do is to get one collection from a large taxpayer, and this amount already returns the investment!”

Since then, the BIR has expanded their use of the SAS Data Warehouse to include other third-party information enhancing their Single Taxpayer View initiatives for a more accurate and extensive view of taxpayer collection performance.

Today, with the success of the SAS Data Warehouse project, the BIR is spearheading the Philippine government’s vision of a National Programs Performance Management. This is initiated through the current BIR projects, namely, the Revenue Watch Dashboard and Local Government Unit Revenue Assurance. These are two projects that are supported and endorsed by the President of the Republic of the Philippines as stated in her 2007 State of the Nation Address.

Today’s announcement came at SAS Global Forum, the largest annual SAS users group conference, attended by more than 3,000 business users of SAS software and solutions.

About HSBC Holdings PLC

HSBC Holdings plc serves over 125 million customers worldwide through around 10,000 offices in 83 countries and territories in Europe, the Asia-Pacific region, the Americas, the Middle East and Africa. With assets of some $2,354 billion at Dec. 31, 2007, HSBC is one of the world’s largest banking and financial services organizations. ¹ HSBC is marketed worldwide as “the world’s local bank.” Additional information about HSBC Holdings plc is available at www.hsbc.com.

[1] HSBC Annual Results

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN., Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

About Philippines Bureau of Internal Revenue

The mission of the Bureau of Internal Revenue (BIR) of the Republic of the Philippines is to raise revenue for the government through the efficient collection of taxes, provide quality service to taxpayers and to ensure impartial and uniform enforcement of tax laws. In its role as the tax collection agency of the Philippines, the BIR is the foundation of the economy contributing to almost 70 percent of annual country revenues. Additional information about the BIR is available at www.bir.gov.ph.

About SAS

Back to Recent SAS Press Releases

Copyright © SAS Institute Inc. All Rights Reserved.